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Center for Hormone Research, Murdoch Childrens Research Institute, Parkville, Victoria, Australia
The insulin-like growth factor (IGF) system is essen-
tial for epidermal homeostasis. Insulin-like growth
factor binding protein 3 (IGFBP-3), a modulator of
IGF action that also exhibits IGF-independent activ-
ity, is localized to selected keratinocytes in the basal
epidermal layer and may thus contribute to keratino-
cyte differentiation. We have utilized the human ker-
atinocyte cell line, HaCaT, to examine the effect of
calcium on the regulation of components of the IGF
system. Western ligand and northern blot analyses
revealed secreted IGFBP-3 and IGFBP-3 mRNA
were reduced by an elevation in calcium levels in the
culture medium. At 1.0 and 1.2 mM CaCl2 culture
conditions IGFBP-3 abundance was reduced to
36% 6 1.6% and 26% 6 7.1%, respectively, of that
from cells grown at 0.03 mM CaCl2. IGFBP-3
mRNA levels in 0.7 mM and 1.2 mM CaCl2 were
reduced to 46% 6 17.4% and 24% 6 4.6%, respect-
ively, compared with IGFBP-3 mRNA levels at
0.03 mM CaCl2. The observed reduction of IGFBP-3
was not associated with IGFBP-3 proteolysis. In con-
trast IGF-I receptor protein and mRNA levels
remained unchanged. The IGF-I stimulated prolif-
erative response of HaCaT keratinocytes showed that
under low (0.03 mM) and high (1.2 mM) CaCl2 con-
ditions IGF-I at 100 and 1000 ng per ml similarly
increased cell number 2.4- and 2.7-fold, respectively,
with similar dose±response curves. HaCaT keratino-
cytes grown under medium (0.7 mM) and high
(1.2 mM), but not low (0.03 mM), CaCl2 conditions
for 21 d revealed an induction of pro®laggrin
mRNA, a marker of keratinocyte differentiation.
These studies indicate that the exposure of HaCaT
keratinocytes to elevated calcium levels is associated
with a decline in IGFBP-3 but not IGF-I receptor
levels. These ®ndings suggest a potential mechanism
for the distribution of IGFBP-3 in the epidermis,
which may be involved in the process of keratinocyte
differentiation. Key words: calcium/epidermis/IGFBP-3/
IGF-IR/keratinocyte. J Invest Dermatol 116:491±497,
2001
I
n epidermal differentiation keratinocytes undergo a complex
series of biochemical and morphologic transformations
leading to terminally differentiated corneocytes.
Differentiation of keratinocytes begins in the basal layer
where daughters of stem cells become transit amplifying cells.
Following a ®nite number of divisions transit amplifying cells leave
the basal layer and continue to metamorphose as they migrate
through the layers of the epidermis (Jones and Watt, 1993; Fuchs
and Byrne, 1994). Calcium gradients are a critical factor in the
process of keratinocyte differentiation (Hennings and Holbrook,
1983; Yuspa et al, 1988; Pillai et al, 1990; Bikle and Pillai, 1993).
The insulin-like growth factor (IGF) system is crucial for normal
epidermal growth and differentiation as evidenced by IGF-I
receptor (IGF-IR) knockout mice, which possess extremely
underdeveloped epidermis with no spinous layer (Liu et al, 1993).
Studies concerning the expression of components of the IGF
system in skin imply that IGF-I acts in a paracrine manner (Han
et al, 1987; Tavakkol et al, 1992; Hodak et al, 1996; Rudman et al,
1997). In particular, IGF-I in skin is produced by dermal ®broblasts,
epidermal melanocytes (Tavakkol et al, 1992), and stratum
granulosum keratinocytes (Rudman et al, 1997), and acts on IGF-
IRs localized in the basal layer of the epidermis (Krane et al, 1992).
Cultured keratinocytes have been shown to respond to dermally
derived IGF-I (Barreca et al, 1992). We recently demonstrated that
IGF binding protein-3 (IGFBP-3), known to possess both IGF
dependent and independent activity (Jones and Clemmons, 1995;
Valentinis et al, 1995; Rajah et al, 1997), is the major binding
protein in the epidermis, is expressed exclusively by selected basal
keratinocytes (Batch et al, 1994; Wraight et al, 1997), and thus
colocalizes with epidermal IGF-IR (Krane et al, 1992). Our in vitro
studies revealed that under basal conditions IGFBP-3 is the major
IGFBP produced by cultured human keratinocytes and that its
expression is inhibited by transforming growth factor b1 (Murashita
et al, 1995; Edmondson et al, 1999), an antiproliferative and
prodifferentiation stimulus for keratinocytes (Shipley et al, 1986;
Glick et al, 1994). Furthermore we have shown that IGFBP-3 is
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also the major IGFBP produced by the immortalized keratinocyte
cell line, HaCaT, and has a net inhibitory effect on IGF-I
stimulated proliferation (Wraight and Werther, 1995). IGFBP-3
may therefore be a critical factor in the normal growth and
maturation of keratinocytes.
In this study, we have utilized HaCaT keratinocytes to assess the
effect of increasing calcium concentration on components of the
IGF system, namely abundance of IGFBP-3 in conditioned
medium (CM), cell associated IGF-IR expression, and IGF-I
stimulated growth. We have further examined potential mechan-
isms involved in the regulation of these components of the IGF
system following an elevation of calcium levels.
MATERIALS AND METHODS
Materials Keratinocyte growth medium consisting of keratinocyte
serum-free medium (SFM) with bovine pituitary extract (BPE),
recombinant epidermal growth factor (rEGF), 0.25% Trypsin-1 mM
EDTA, and 0.09 mM CaCl2 were all obtained from Gibco (Grand
Island, NY). Keratinocyte basal medium (KBM; without growth factors
and calcium), epidermal growth factor (EGF), insulin, hydrocortisone,
and BPE were purchased from Clonetics (San Diego, CA). Phosphate-
buffered saline (calcium and magnesium free) and fetal bovine serum
(FBS) were from Trace America (Miami, FL). Tissue culture ¯asks and
24-well plates were obtained from Nunc (Roskilde, Denmark). RIA
grade bovine serum albumin (BSA), aprotinin, and phenylmethylsulfonyl
¯uoride (PMSF) was obtained from Sigma (St. Louis, MO).
Nitrocellulose ®lters (0.45 mM) were obtained from Schleicher and
Schuell (Dassel, Germany). X-ray ®lms (X-Omat AR) were purchased
from Kodak (Rochester, NY). 125I-IGF-I (2000 Ci per mmol), 14C
protein molecular weight (14±22 kDa) markers, and 32P-dCTP (3000 Ci
per mmol) were purchased from Amersham (Buckinghamshire, U.K.).
125I-IGFBP-3 was a generous gift from Associate Prof. L. Bach
(Department of Medicine, University of Melbourne, Austin, and
Repatriation Medical Center, Heidelberg, Australia). The cDNA for
human IGFBP-3 was kindly provided by Dr. S. Shimasaki (Whittier
Institute, La Jolla, CA; Shimasaki and Ling, 1991). The cDNA for
mouse 18srRNA was kindly provided by Ms Leah Heffernan (Center for
Hormone Research, Melbourne, Australia). The cDNA for human
pro®laggrin was kindly provided by Professor P. Fleckman (University of
Washington, Seattle, WA; Presland et al, 1992). Recombinant human
IGF-I was a gift from Dr. A. SkoÈttner (Pharmacia-Upjohn, Sweden).
The cDNA random priming kit was purchased from Boehringer
Mannheim (Sydney, Australia). Zeta-probe nylon membrane was
purchased from Bio-Rad (Sydney, Australia).
Keratinocyte culture
Cell culture The immortalized keratinocyte cell line HaCaT was
generously provided by Prof. N. Fusenig (German Cancer Research
Center, Heidelberg, Germany). HaCaT cells were maintained as
monolayer cultures in 5% CO2 at 37°C in Dulbecco's modi®ed Eagle's
medium (DMEM) supplemented with 10% FBS. For experiments,
HaCaT keratinocytes were grown in 24-well plates in keratinocyte
growth medium (0.09 mM CaCl2; Gibco) and at 1 d postcon¯uence
(1DPC) medium was changed to keratinocyte basal medium (KBM
minus CaCl2 and growth factors) for 24 h. KBM was then changed to
experimental medium: KBM/0.02% BSA containing EGF (5 ng per ml),
insulin (5 mg per ml), hydrocortisone (0.5 mg per ml), and BPE (30 mg
per ml) with either 0.03, 0.1, 0.7, 1.0, or 1.2 mM CaCl2 (1 ml per
well). Cells were exposed to experimental medium (in quadruplicate) for
24 h followed by another 48 h of the identical medium. The total
experimental period was 96 h.
Western ligand blotting (WLB) At the end of the incubation period
(total, 96 h) 2 d conditioned medium (CM) was collected and cell
numbers were determined by the amido black assay (Schulz et al, 1994).
WLB of keratinocyte CM (250 ml per 1000 ml, triplicates) was as
previously described (Edmondson et al, 1999) with sodium dodecyl
sulfate (SDS) polyacrylamide gel electrophoresis performed according to
the method of Laemmli (1970). Filters were exposed overnight to a
phosphorimaging screen and were densitometrically assessed using Image
Quant software (Storm, Molecular Dynamics, Sunnyvale, CA). For
statistical analysis, IGFBP-3 band densities were corrected for cell
number, averaged, and then compared with the average band density of
IGFBP-3 in the 0.03 mM CaCl2 treated sample. Combined data (n = 3)
are represented as the relative abundance of IGFBP-3, expressed as a
percentage, compared with that of cells grown at 0.03 mM CaCl2.
RNA isolation and northern analysis Keratinocytes (in 24-well plates
or six-well plates) were treated as described above. At the end of the
®nal 48 h experimental period total RNA (duplicates or quadruplicates,
n = 3) was isolated using the RNAzol extraction kit (Tel-Test,
Friendswood, TX) and quanti®ed spectrophotometrically at 260 nm.
Northern blot analysis was performed on 15 mg total RNA after
electrophoresis in a 1.0% formaldehyde agarose gel and transferal to
Zeta-probe nylon membrane. Filters were hybridized with a random-
primed, 32P-labeled IGFBP-3 cDNA (average speci®c activity was
1 3 109 dpm per mg) at 65°C overnight by continuous rolling in a
Hybaid oven (Bartelt, Melbourne, Australia). Filters were washed in 2±
0.1 3 sodium citrate/chloride buffer/0.1% SDS at 65°C, exposed to a
phosphorimaging screen for overnight exposure, and densitometrically
assessed using Image Quant software (Storm). RNA integrity was
con®rmed by addition of 1 mg per ml ethidium bromide to the
formaldehyde agarose gel. To account for total RNA loading variation
®lters were stripped of IGFBP-3 cDNA according to manufacturer's
instructions and rehybridized with 32P-labeled 18S rRNA cDNA in a
similar manner to that described above. Filters were exposed to a
phosphorimaging screen for 30 min and were densitometrically assessed
as described above. For analysis IGFBP-3 mRNA band densities were
corrected for loading using the 18S rRNA band intensity for the
corresponding lane. Combined data were then represented as the relative
levels of IGFBP-3 mRNA, expressed as a percentage, compared with
IGFBP-3 mRNA levels when cells were grown in the presence of
0.03 mM CaCl2. For analysis of pro®laggrin mRNA abundance HaCaT
keratinocytes were plated in six-well plates and exposed to experimental
conditions as described above (cell culture section). Cells were grown to
21 d after exposure to experimental medium, with medium being
replaced every 4 d. Total RNA was extracted and 25 mg was subjected
to northern analysis as described for IGFBP-3 but using a pro®laggrin
cDNA as the labeled probe.
IGFBP-3 proteolysis analysis Proteolysis of 125I-IGFBP-3 (30,000
cpm per sample) by HaCaT cells grown under low (0.03 mM) and high
(1.2 mM) CaCl2 was determined under two conditions: (i) when added
to cells for overnight incubation at 37°C and (ii) when added to CM
(500 ml) collected from HaCaT cells grown under the conditions
described and incubated overnight at 37°C. Duplicate samples from two
sets of experiments were run on 12% SDS-PAGE and analyzed by
phosphorimaging. Control samples included experimental medium
(KBM/0.02% BSA/EGF, insulin, hydrocortisone, BPE), (i) 125I-IGFBP-
3 without incubation, (ii) 125I-IGFBP-3 with the addition of pregnant
human serum and overnight incubation at 37°C, (iii) 125I-IGFBP-3 and
overnight incubation at 37°C. All control samples were diluted in KBM/
0.02% BSA.
Western immunoblotting HaCaT keratinocytes were grown in six-
well plates under low (0.03 mM), medium (0.7), and high (1.2 mM)
CaCl2 culture conditions as described above. At the end of the
experimental period cells were lyzed in a buffer containing 50 mM
HEPES pH 7.4, 150 mM NaCl, 150 mM MgCl2, 1 mM EGTA, 10%
glycerol, 1% Triton X-100, 100 mM NaF, 100 mg per ml aprotinin, and
10 mM PMSF, then 30 mg of lysate loaded onto a denaturing 7%
polyacrylamide gel followed by transfer onto an Immobilon-p membrane
(Millipore, Bedford, MA). Even loading of samples was con®rmed by
Ponceau red staining. Membranes were incubated with the anti-IGF-I
receptor antibody C20 (Santa Cruz Biotechnology, Santa Cruz, CA;
25 ng per ml in 150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 0.1% Tween
20) for 1 h at room temperature and developed using the Vistra ECF
Western blotting kit (Amersham). Band intensity (duplicates from two
separate experiments) was quanti®ed using ImageQuant software. Data
were expressed as the relative abundance of IGF-IR, expressed as a
percentage, in comparison with IGF-IR abundance in cells grown under
0.03 mM CaCl2.
RNase protection assay Experimental conditions and total RNA
isolation were as described above. IGF-I receptor mRNA and
glyceraldehyde phosphate dehydrogenase (GAPDH) mRNA were
quanti®ed using a commercially available ribonuclease protection assay
kit (RPAII, Ambion, Austin, TX) and antisense probes (pTRI-IGFR-
human and pTRI-GAPDH-human; Ambion). In brief, 20 mg of total
RNA was hybridized with 2 3 105 cpm IGF-I receptor antisense RNA
probe and 1 3 104 cpm GAPDH RNA antisense probe for 18 h at
42°C and then digested with 12 U per ml RNaseA/500 U per ml
RNaseT1 for 30 min. Protected fragments were visualized by
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phosphorimager analysis following electrophoresis through a 5%
acrylamide/8 M urea gel. Band density was quanti®ed using ImageQuant
software (Molecular Dynamics). IGF-IR mRNA band density (duplicates
from three separate experiments) was initially expressed relative to the
GAPDH band intensity in the same sample. Data were ®nally
represented as the relative levels of IGF-IR mRNA, expressed as a
percentage, in comparison with IGF-IR mRNA levels when cells were
grown under 0.03 mM CaCl2 culture conditions.
IGF-I proliferation assays HaCaT keratinocytes were plated at
10,000 cells per well in a 96-well plate and after 24 h in complete
KSFM the medium was changed to KBM without CaCl2 for 24 h. The
medium was then changed to experimental medium (KBM/0.02% BSA
and the above mentioned growth factors) with either 0.03 mM or
1.2 mM CaCl2 and IGF-I at concentrations ranging from 0 to 1 mg per
ml. Experimental medium was then replenished at 24 h, 72 h, and
120 h. At the end of the experimental period (168 h) cell number was
determined by an amido black cell counting assay (Schulz et al, 1994).
Each set of experiments (n = 2) was performed in eight replicates. IGF-I
dose±response curves for either 0.03 or 1.2 mM CaCl2 culture
conditions were expressed as the relative optical density (OD; cell
number), expressed as a percentage, compared with that of cells grown
in 0 ng per ml IGF-I. Calculations for EC50 values for IGF-I (ng per
ml) stimulated proliferation of HaCaT keratinocyte under low
(0.03 mM) and high (1.2 mM) CaCl2 were performed using Prism
Graph Pad software (San Diego, CA).
Statistical analysis All data were assessed statistically by one-way
ANOVA using a Dunnett's multiple comparison post test or Newman±
Kuels multiple comparison post test (Prism Graph Pad software).
RESULTS
HaCaT keratinocytes exposed to medium and high calcium
conditions express pro®laggrin mRNA Northern blot
analysis of total RNA extracted from HaCaT keratinocytes
exposed to low (0.03 mM), medium (0.7 mM), and high
(1.2 mM) CaCl2 concentrations for 21 d was performed to assess
pro®laggrin mRNA abundance. As shown in Fig 1, pro®laggrin
mRNA, at the expected size of 13 kb (Presland et al, 1992), is only
detected in samples extracted from HaCaT keratinocytes grown
under medium and high calcium conditions.
IGFBP-3 abundance is reduced by increased calcium
levels IGFBP abundance in conditioned medium collected
from HaCaT cells grown under increasing CaCl2 conditions was
determined by WLB. IGFBP-3 abundance, following correction
for cell number, is represented as the relative abundance of IGFBP-
3, expressed as a percentage (6 SEM), compared with that of cells
grown at 0.03 mM CaCl2. As shown in Fig 2(a), a representative
WLB of HaCaT conditioned medium, IGFBP-3 abundance
decreased with increasing calcium concentration. The combined
densitometric analysis of WLBs revealed that at 1.0 and 1.2 mM
CaCl2 IGFBP-3 abundance was reduced to 36% 6 1.6% and
26% 6 7.1%, respectively, of that from cells grown in 0.03 mM
CaCl2 (p < 0.001; Fig 2b). WLB analysis of HaCaT conditioned
medium also con®rmed that an elevation of calcium was not
associated with a gross upregulation of any other IGFBP (Fig 2a).
Elevated calcium levels reduce IGFBP-3 abundance at the
level of mRNA Northern blot analysis of total RNA extracted
from HaCaT keratinocytes exposed to increasing calcium
concentrations was performed to determine whether the observed
regulation of IGFBP-3 levels in HaCaT keratinocyte conditioned
medium was due to regulation of IGFBP-3 mRNA levels.
Figure 3(a) is a representative northern blot of 15 mg total RNA
showing that the predicted IGFBP-3 mRNA band at 2.6 kb (Spratt
et al, 1990) was detected in all samples. Consistent with IGFBP-3
protein levels, IGFBP-3 mRNA levels decreased with increasing
CaCl2 in the medium. The combined densitometric analysis of the
northern analyzes is shown graphically in Fig 3(b) and includes
standardization of IGFBP-3 mRNA bands against the 18 s rRNA
bands from the same sample. Data are represented as the relative
IGFBP-3 mRNA levels, expressed as a percentage (6 SEM), in
comparison with IGFBP-3 mRNA levels when cells were grown
in the presence of 0.03 mM CaCl2. Compared with cells grown at
0.03 mM CaCl2, IGFBP-3 mRNA levels were reduced to
46% 6 17.4% (p < 0.05) and 24% 6 4.6% (p < 0.01) at 0.7 mM
and 1.2 mM CaCl2, respectively.
Exposure of HaCaT keratinocytes to elevated calcium levels
does not induce IGFBP-3 speci®c proteases As an
alternative mechanism for reduced IGFBP-3 levels would have
been induction of a speci®c protease, we also examined for this
possibility. The activation of IGFBP-3 speci®c proteases was
assessed under low (0.03 mM) and high (1.2 mM) CaCl2 culture
Figure 1. HaCaT keratinocytes exposed to medium and high
calcium conditions express pro®laggrin mRNA. Cells were grown
in the presence of low (0.03 mM) CaCl2, medium (0.7 mM), or high
(1.2 mM) CaCl2 for 21 d, total RNA was extracted and assessed for
pro®laggrin mRNA abundance by northern analysis. (a) Pro®laggrin
mRNA (13 kb) was detected only when cells were grown under
medium and high CaCl2 culture conditions. (b) Ethidium bromide
stained gel indicating total RNA loading.
Figure 2. IGFBP-3 abundance is reduced by increased calcium
levels. HaCaT keratinocytes were grown in the presence of increasing
CaCl2 concentrations in the medium for a total of 72 h. Two day
conditioned medium was collected and IGFBP-3 abundance (triplicates)
was detected by WLB using 125I-IGF-I as the ligand. (a) Representative
WLB showing IGFBP-3 detected as a doublet at 38±42 kDa. (b)
Graphical representation of combined densitometric analyses of IGFBP-3
abundance in HaCaT conditioned medium. Results are expressed as the
relative abundance of IGFBP-3, expressed as a percentage (6 SEM),
when compared with IGFBP-3 abundance at 0.03 mM CaCl2. (n = 3)
*p < 0.001 when compared with 0.03 mM CaCl2 conditions.
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conditions to further characterize the reduction of IGFBP-3
abundance in HaCaT keratinocyte conditioned medium.
Proteolytic cleavage of IGFBP-3 may require cell surface
association (Conover et al, 1996). Thus possible proteolysis was
assessed under two experimental conditions: (i) by addition of 125I-
IGFBP-3 to HaCaT keratinocyte medium, conditioned for 2 d, for
overnight incubation at 37°C (Fig 4a; +CM), and (ii) by addition
of 125I-IGFBP-3 to HaCaT keratinocytes directly for overnight
incubation at 37°C (Fig 4b; +cells). At the end of the incubation
period proteolysis of 125I-IGFBP-3 was determined by SDS-PAGE
of samples. Figures 4(a) and 4(b) are representative gels and
indicate that irrespective of incubation conditions proteolytic
fragments of 125IGFBP-3 were not detected under either low
(0.03 mM) or high (1.2 mM) CaCl2 conditions. The control lanes
show that, as expected, 125I-IGFBP-3 could be proteolyzed by
proteases previously described in pregnant human serum (collected
at 36 wk of gestation; 125I-IGFBP-3 + PHS) (Hossenlopp et al,
1990).
IGF-IR protein and mRNA abundance are not altered by
elevated calcium levels HaCaT keratinocyte IGF-IR
abundance under low (0.03 mM), medium (0.7 mM), and high
(1.2 mM) CaCl2 conditions was assessed by western immunoblot of
20 mg of total cellular protein. Figure 5(a) is a representative
western immunoblot showing IGF-IR protein (b subunit) at the
expected size of 120 kDa, and indicates there is no regulation of
IGF-IR protein levels under increasing calcium concentration in
the culture medium. Figure 5(b) represents the combined
densitometric analysis of HaCaT keratinocyte IGF-IR
abundance. Data are shown as the relative abundance of IGF-IR,
expressed as a percentage (6 SEM), in comparison with IGF-IR
abundance at 0.03 mM CaCl2 and con®rms IGF-IR levels do not
change under increased calcium conditions.
Regulation of HaCaT keratinocyte IGF-IR mRNA levels under
low, medium, and high CaCl2 culture conditions was determined
by RNase protection assay (RPA) of total RNA (20 mg).
Figure 5(c), a representative RPA, con®rms the presence of
IGF-IR mRNA at the expected size of 276 nucleotides in all
samples and indicates IGF-IR mRNA did not alter with increasing
CaCl2 in the culture medium. Figure 5(d) shows the combined
densitometric analysis of RPA of IGF-IR mRNA levels. Data are
represented as the relative IGF-IR mRNA levels, expressed as a
percentage (6 SEM), in comparison with IGF-IR mRNA levels
when cells were grown under 0.03 mM CaCl2 culture conditions.
IGF-I mRNA abundance was initially expressed relative to
GAPDH mRNA abundance in the same sample. The densito-
metric analysis con®rmed a lack of IGF-I mRNA regulation in
response to increasing CaCl2 concentration in the HaCaT
keratinocyte culture medium (Fig 5d).
IGF-I stimulated proliferation does not change following an
elevation in calcium levels IGF-I stimulated proliferation of
HaCaT keratinocytes grown under low and high CaCl2 culture
conditions was assessed by amido black assay. Figure 6 shows the
combined HaCaT keratinocyte dose±response curves under low
(0.03 mM) and high (1.2 mM) CaCl2 culture conditions for IGF-I
(0±1000 ng per ml). Data are expressed as the percentage change in
optical density (OD; cell number), expressed as a percentage
(6 SEM), compared with that of cells grown in 0 ng per ml IGF-I.
As indicated, HaCaT keratinocytes grown under low and high
CaCl2 culture conditions proliferate in response to increasing levels
of IGF-I. Speci®cally, under low CaCl2, IGF-I at 100 and 1000 ng
per ml increased cell number to 258% 6 33% and 270% 6 33%,
respectively, when compared with untreated control cells. Under
high CaCl2 IGF-I at 100 and 1000 ng per ml increased cell number
to 237% 6 33% and 232% 6 40%, respectively, when compared
with untreated control. In the absence or presence of IGF-I, an
elevated calcium concentration increased ®nal cell number by
approximately 50%±80%, as expected (Gniadecki, 1996),
independent of IGF-I concentration (data not shown). Figure 6
shows that the effect of IGF-I is highly concentration dependent
even in the context of the calcium effect on growth. Under low
Figure 3. Elevated calcium levels reduce IGFBP-3 abundance at
the level of mRNA. Total RNA was extracted from HaCaT
keratinocytes exposed to increasing CaCl2 concentration in the culture
medium for a period of 72 h. (a) Representative northern blot showing
IGFBP-3 mRNA (2.6 kb) in all samples (duplicate). Fb, ®broblast total
RNA used as a positive control for IGFBP-3 mRNA. (b) Graphical
representation of combined densitometric analyses of IGFBP-3 mRNA
levels. Data are represented as the relative levels of IGFBP-3 mRNA,
expressed as a percentage (6 SEM), when compared with IGFBP-3
mRNA levels at 0.03 mM CaCl2. (n = 3) *p < 0.05 and **p < 0.01
when compared with 0.03 mM CaCl2 conditions.
Figure 4. Exposure of HaCaT keratinocytes to elevated calcium
levels does not induce IGFBP-3 speci®c proteases. Proteolysis of
nonglycosylated 125I-IGFBP-3 was assessed under low (0.03 mM) and
high (1.2 mM) CaCl2 culture conditions in the absence (a) or presence
(b) of HaCaT keratinocytes. At the end of the incubation period
proteolysis of 125I-IGFBP-3 was determined by SDS-PAGE and
autoradiography. The representative autoradiograph shows 125I-IGFBP-3
as a 30-kDa band and a lack of proteolytically cleaved fragments in all
experimental samples. Proteolytic fragments of 125I-IGFBP-3 were only
detected in the control lane to which pregnant human serum was added
(BP-3 + PHS). BP-3 (no inc. 37°C) = 125I-IGFBP-3 and represents the
starting material. BP-3 = 125I-IGFBP-3/experimental medium plus
overnight incubation at 37°C and indicates a lack of cleavage in
experimental medium that has not been conditioned by HaCaT
keratinocytes. M, 14C-protein markers.
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and high CaCl2 culture conditions, the EC50 values for IGF-I (ng
per ml)-stimulated proliferation of HaCaT keratinocytes were not
signi®cantly different at 8.9 6 0.3 ng per ml and 5.9 6 1.8 ng per
ml, respectively.
DISCUSSION
The basal layer of the epidermis comprises self-renewing stem cells
and transit amplifying cells, which represent the early stages of
terminally differentiating keratinocytes (Jones and Watt, 1993;
Fuchs and Byrne, 1994). Keratinocyte differentiation or maturation
is highly reliant on epidermal calcium gradients (Bikle and Pillai,
1993). We have previously shown that IGFBP-3 protein and
mRNA is localized and limited to speci®c keratinocytes in the basal
layer and thus questioned whether calcium, a regulator of
keratinocyte differentiation (Hennings and Holbrook, 1983;
Yuspa et al, 1988; Pillai et al, 1990; Bikle and Pillai, 1993), may
modulate the expression of IGFBP-3 by keratinocytes. In this study
using HaCaT keratinocytes elevated calcium levels led to signi®-
cantly reduced IGFBP-3 abundance via reduction of its mRNA.
Proteases provide another tier at which IGFBP abundance can be
regulated (Jones and Clemmons, 1995). Although IGFBP-3 speci®c
proteases are secreted by HaCaT keratinocytes, albeit in an inactive
form (Xu et al, 1997), and are found in blister ¯uid of human skin
(Xu et al, 1995), our data indicate that this mechanism is not
involved in regulation of IGFBP-3 abundance following an
elevation in calcium levels in the culture medium. Increasing
calcium concentration in culture medium of HaCaT keratinocytes
was also associated with the induction of pro®laggrin mRNA, a
marker of terminal differentiation (Presland et al, 1992). These data
therefore indicate that increasing calcium concentration is associ-
ated with a loss of IGFBP-3 expression and implicate calcium as a
regulator of IGFBP-3 abundance in the skin. As an elevation in
calcium levels can induce keratinocyte differentiation these studies
also suggest a possible role for IGFBP-3 in epidermal differenti-
ation.
As increasing calcium concentration is a stimulus for the
induction of keratinocyte differentiation it is tempting to suggest,
on the basis of these ®ndings, that in vivo the cells in the basal layer
lacking IGFBP-3 protein represent transit amplifying keratinocytes.
Switching off IGFBP-3 production may therefore be a prerequisite
for the initial stages of basal keratinocyte differentiation. Moreover
our analysis of psoriatic skin, in which hyperproliferation is
characteristic of the disease, revealed that IGFBP-3 expression
was tightly associated with basal layer of the suprapapillary
epidermis where most keratinocytes are quiescent (Wraight et al,
1997).
An involvement of IGFBPs in cellular differentiation has been
proposed in a number of cell types (Hoe¯ich et al, 1996; James et al,
1996; Velez-Yanguas et al, 1996; Yeh et al, 1997; Jehle et al, 1999;
MacDonald et al, 1999). A reduction of IGFBP-3 levels coincides
with the induction of differentiation of porcine myogenic cells and
human bone marrow stromal cells (Johnson et al, 1999; Yang et al,
1999). An increase in IGFBP-3 levels during differentiation of the
human osteosarcoma cell line HL-60, however, suggests the
possible involvement of this IGFBP in cellular differentiation is
via cell type speci®c mechanisms (Velez-Yanguas et al, 1996). In
further support of IGFBPs playing a role in cellular differentiation,
Figure 6. IGF-I stimulated proliferation does not change
following an elevation in calcium levels. HaCaT keratinocytes were
exposed to increasing doses of IGF-I (0±1000 ng per ml) in low
(0.03 mM) or high (1.2 mM) CaCl2 culture conditions. At the end of
the experimental period HaCaT cell number was determined by amido
black assay. IGF-I dose±response curves for low or high CaCl2 culture
conditions are expressed as the relative OD (cell number), expressed as a
percentage compared (6 SEM) with that of cells grown at 0 ng per ml
IGF-I. *p < 0.001 compared with 0 ng per ml IGF-I/0.03 mM CaCl2
(n = 2); ***p < 0.001 compared with 0 ng per ml IGF-I/1.2 mM
CaCl2; **p < 0.01 compared with 0 ng per ml IGF-I/1.2 mM CaCl2.
Figure 5. IGF-IR protein and mRNA levels are not altered by elevated calcium levels. HaCaT keratinocytes were grown under low
(0.03 mM), medium (0.7 mM), and high (1.2 mM) CaCl2 culture conditions and cell lysates or total RNA were extracted at the end of the 72 h
experimental period. (a) Representative western immunoblot of 20 mg cell lysate (duplicate) probed with a polyclonal antibody to the b subunit of the
IGF-IR. IGF-IR b subunit was detected in all samples at 120 kDa. (b) Combined densitometric analysis of IGF-IR levels determined by western
immunoblot. Data are expressed as the relative abundance of IGF-IR at medium and high CaCl2 culture conditions, expressed as a percentage
(6 SEM), when compared with IGF-IR abundance at low CaCl2 culture conditions (n = 2). (c) Representative RNase protection assay of total RNA
showing IGF-IR mRNA (276 nucleotides) and GAPDH mRNA (316 nucleotides) in all samples (duplicates); (d) Combined densitometric analyses of
IGF-IR mRNA levels relative to GAPDH mRNA levels in each sample. Data are represented as the relative levels of IGF-IR mRNA, expressed as a
percentage (6 SEM), when compared with IGF-IR mRNA levels at 0.03 mM CaCl2 (n = 3).
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recent studies in C2 myoblasts have conclusively shown that a
reduction in IGFBP-5 levels is essential for IGF-I induced
differentiation (James et al, 1996).
In contrast to other cell types (Johnson et al, 1999; Yang et al,
1999), we did not observe the upregulation of any other IGFBPs
even when IGFBP-3 was suppressed following the elevation of
calcium levels in the culture medium of HaCaT keratinocytes.
Conversely, when cultured in the presence of high calcium levels
HaCaT keratinocytes were shown to secrete IGFBP-6. In
particular, Kato et al (1995) and Marinaro et al (1999) describe
the presence of IGFBP-6 in HaCaT conditioned medium when
cells were grown in serum-free, high calcium (1.8 mM CaCl2)
medium. Using several techniques, including RIA and WLB using
125I-IGF-II, which has a higher af®nity for IGFBP-6, we were
unable to demonstrate the induction of secreted IGFBP-6 by an
increase in the calcium level in the medium (data not shown). It
remains possible that the lack of IGFBP-6 expression in our studies
is related to differences between culture media. Our ®ndings are
consistent, however, with our in vivo studies showing a lack of
IGFBP-1, -2, -4, -5, and -6 in human epidermis, except in
specialized sebaceous glands and sweat glands (Batch et al, 1994).
Unlike IGFBP-3, IGF-IR protein and mRNA were not
regulated by increasing calcium levels in HaCaT keratinocyte
medium. This observation is not surprising as in vivo IGF-IRs have
been detected on all cells in the basal layer, including those
keratinocytes that do not express IGFBP-3 (Krane et al, 1992;
Wraight et al, 1997). Furthermore, IGF-I is known to stimulate
keratinocyte proliferation (Wraight and Werther, 1995; Barreca
et al, 1992) but it is likely that IGF-I is also essential for keratinocyte
differentiation. In support of this proposal, mice lacking the IGF-
IR exhibit abnormally thin, transluscent epidermis with no
differentiated spinous layer (Liu et al, 1993). A role for IGF-I in
differentiation has been described for many cell systems including
adipocytes (Smith et al, 1988), neuroblastoma cell lines (Kim et al,
1997; Chambery et al, 1999), myoblasts (Florini et al, 1986; James
et al, 1996), and chondrocytic cell lines (Takigawa et al, 1997). The
IGF-IR may thus elicit both a proliferative and a differentiative
response in keratinocytes, similar to that recently described for
hemopoietic cells (Valentinis et al, 1999).
Finally this study showed that there was no change in IGF-I
stimulated proliferation when HaCaT keratinocytes were exposed
to elevated calcium levels. Although a decrease in IGFBP-3 levels
would potentially increase the availability of IGF-I to its cell surface
receptor, HaCaT keratinocytes were not more sensitive to IGF-I
mitogenic stimulation. These data suggest that postreceptor signal-
ing mechanisms are likely to play a more important role in
regulating IGF-I-induced proliferation following exposure to
increasing calcium.
Calcium gradients play an essential role in epidermal strati®cation
(Hennings and Holbrook, 1983; Yuspa et al, 1988; Pillai et al, 1990;
Bikle and Pillai, 1993). Thus these data indicate that calcium may
regulate the abundance of keratinocyte-derived IGFBP-3, but not
IGF-IR, in the epidermis and suggest a potential mechanism for the
distribution of IGFBP-3 in the epidermis, which may be involved
in the process of keratinocyte differentiation.
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